Singapore has approved the use of the Nuvaxovid vaccine by Novavax in its National Vaccination Programme for individuals aged 18 years and above for both the primary and booster vaccination shot.
RSS Feed | The Epoch Times
Singapore has approved the use of the Nuvaxovid vaccine by Novavax in its National Vaccination Programme for individuals aged 18 years and above for both the primary and booster vaccination shot.
RSS Feed | The Epoch Times